
GIFLF
Healthcare · Drug Manufacturers - General · $8.66B market cap
$12.720.00 (0.0%)Nov 13, 9:30 AM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Jul 28, 2026 | After the close | — | 0.26 | — |
| Jul 29, 2025 | After the close | — | 0.20 | — |
| May 12, 2025 | Before the open | — | 0.09 | — |
| Feb 26, 2025 | Before the open | — | 0.11 | — |
| Jul 30, 2024 | Before the open | — | 0.02 | — |
| Feb 29, 2024 | Before the open | — | 0.09 | — |
| Aug 28, 2022 | After the close | — | 0.14 | — |
| Jul 29, 2021 | Before the open | 0.22 | 0.24 | +9.1% |
| May 3, 2021 | After the close | 0.19 | 0.17 | -10.5% |
| Feb 26, 2021 | Before the open | 0.20 | 0.25 | +25.0% |
| Nov 5, 2020 | Before the open | 0.26 | 0.32 | +23.1% |
| Jul 29, 2020 | After the close | 0.28 | 0.31 | +10.7% |
| Apr 21, 2020 | Before the open | 0.26 | 0.22 | -15.4% |
Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally. It operates through four segments: Biopharma, Diagnostic, Bio Supplies, and Others. The company offers various hemoderivatives from human plasma for immunology, infectious diseases, hepatology, intensive care,…
| Feb 27, 2020 |
| Before the open |
| 0.30 |
| 0.28 |
| -6.7% |
| Oct 28, 2019 | After the close | 0.27 | 0.25 | -7.4% |
| Jul 30, 2019 | After the close | 0.28 | 0.30 | +7.1% |
| May 6, 2019 | After the close | 0.23 | 0.22 | -4.3% |
| Feb 27, 2019 | After the close | 0.26 | 0.22 | -15.4% |
| Nov 4, 2018 | After the close | 0.27 | 0.26 | -3.7% |
| Jul 26, 2018 | After the close | 0.26 | 0.29 | +11.5% |
| May 2, 2018 | After the close | 0.22 | 0.24 | +9.1% |
| Feb 27, 2018 | After the close | 0.24 | 0.13 | -45.8% |